In vivo antitumor effects of murine interferon-γ-inducing factor/interleukin-18 in mice beaing syngeneic Meth A sarcoma malignant ascites

Cancer Immunology Immunotherapy

Volumn 43, Issue 6, 1997, Pages 361-367

  Micallef, Mark J ^a   Yoshida, Kenshi ^a   Kawai, Sachiko ^a   Hanaya, Toshiharu ^a   Kohno, Keizo ^a   Arai, Shigeyuki ^a   Tanimoto, Tadao ^a   Torigoe, Kakuji ^a   Fujii, Mitsukiyo ^a   Ikeda, Masao ^a   Kurimoto, Masashi ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

Antitumor effect; IFN ; Immunological memory; Interleukin 18; NK cells

Indexed keywords

GAMMA INTERFERON; INTERFERON INDUCING AGENT; INTERLEUKIN 18; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; IMMUNOLOGICAL MEMORY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SARCOMA; SPLEEN CELL;

ANIMALS; ASCITES; CYTOKINES; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INTERFERON INDUCERS; INTERFERON TYPE II; INTERLEUKIN-18; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; SARCOMA, EXPERIMENTAL;

EID: 8044244220     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050345     Document Type: Article

References (29)

1. Baxivanis CN, Reclos GJ, Gritzapas AD, Dedousis GV, Missitzis I, Papamichail M (1993) Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 72:491
2. Chen LK, Tourveille B, Burns GF, Bach FH, Matieu-Mahul D, Sasportes M, Bensussan A (1986) Interferon: a cytotoxic T-lymphocyte differentiation signal. Eur J Immunol 16:767
3. De Leo AB (1994). Tumor rejection antigens of the chemically induced BALB/c Meth A sarcoma. Immunol Ser 61:31
4. + MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo. J Immunol 154:4613
5. Fu Y-X, Watson GA, Kasahara M, Lopez DM (1991) The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. J Immunol 146:783
6. Gately MK, Warrier RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, Anderson TD, Sarmiento U, Hubbard BR, Murphy M (1994) Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int Immunol 6:157
7. + T-cells show antitumor activity against syngeneic fibrosarcoma. Cancer Res 53:106
8. Hillman GG, Younes E, Visscher D, Ali E, Lam JS, Montecillo E, Pontes JE, Haas GP, Puri RK (1995) Systemic treatment with interleukin-4 induces regression of pulmonary metastasis in a murine renal cell carcinoma model. Cell Immunol 160:257
9. Maraskovsky E, Chen WF, Shortman K (1989) IL-2 and IFN-γ are two nessesary lymphokines in the development of cytotoxic T-cells. J Immunol 143:1210
10. Matzinger P (1991) The JAM test-A simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185
11. McAdam AJ, Pulaski BA, Harkins SS, Hutter EK, Lord EM, Frelinger JG (1995) Synergistic effects of co-expression of the Th1 cytokines IL-2 and IFN-γ on generation of murine tumor-reactive cytotoxic cells. Int J Cancer 61:628
12. Mercurio AM, Schwarting GA, Robbins PW (1984) Glycolipids of the mouse peritoneal macrophage: alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation. J Exp Med 160:1114
13. Micallef M (1993) Immunoregulatory cytokine production by tumor-bearing rat spleen cells and its modulation by bleomycin. Anti-Cancer Drugs 4:213
14. Micallef M, Hosokawa M, Shibata T, Nakane A, Yang Z-Y, Minagawa T, Kobayashi H (1991) Immunoregulatory cytokine release in rat spleen cell cultures after treatment with bleomycin and its analogues in vivo. Cancer Immunol Immunother 33:33
15. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, Torigoe K, Fujii M, Ikeda M, Fukuda S, Kurimoto M (1996) Interferon gamma inducing factor enhances T helper type 1 cytokine production by stimulated human T cells: synergism with interleukin 12 on interferon gamma production. Eur J Immunol 26:1647
16. + cytotoxic T cell lines against melanoma. Cancer Immunol Immunother 39:172
17. Nakamura K, Okamura H, Wada M, Nagata K, Komatsu T, Tamura T (1989) Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 57:590
18. Nakamura K, Okamura H, Nagata K, Komatsu T, Tamura T (1993) Purification of a factor which provides a costimulatory signal for gamma interferon production. Infect Immun 61:64
19. Nakashima Y, Mita S, Takatsu K, Ogawa M (1993) Interleukin-5 induces tumor suppression by peritoneal exudate cells in mice. Cancer Immunol Immunother 37:227
20. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukada Y, Tanabe F, Akita K, Torigoe K, Okura T, Fukuda S, Kurimoto M (1995) A novel costimulatory factor for IFN-γ induction found in the liver of mice caused endotoxic shock. Infect Immun 63:3966
21. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M (1995) Cloning of a novel cytokine that induces IFN-γ production by T cells. Nature 378:88
22. Suttles J, Schwarting GA, Hougland MW, Stout RD (1987) Expression of asialo GM1 on a subset of adult murine thymocytes: histological localization and demonstration that the asialo GM1-positive subset contains both the functionally mature and the proliferating thymocyte subpopulations. J Immunol 138:364
23. Tsutsui H., Nakanishi K, Matsui K, Higashino K, Okamura H, Miyazawa Y, Kaneda K (1996) Interferon γ-inducing factor (IGIF) upregulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol (in press)
24. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Micallef M, Fujii M, Torigoe K, Tanimoto T, Fukuda S, Ikeda M, Okamura H, Kurimoto M (1996) Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156:4274
25. Yim CY, McGregor JR, Kwon OD, Bastian NR, Rees M, Mori M, Hibbs JB Jr, Samlowski WE (1995) Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor. J Immunol 155:4382
26. Young MRI, Wright MA (1992) Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: γ interferon plus tumor necrosis factor a synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis. Cancer Res 52:6335
27. Zeh HJ, Hurd S, Storkus WJ, Lotze MT (1993) Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer. J Immunother 14:155
28. + T cell activity. J Immunol 148:648
29. Zou J-P, Yamamoto N, Fujii T, Takenaka H, Kobayashi M, Herrmann SH, Wolf SF, Fujiwara H, Hamaoka T (1995) Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-γ production by antitumor T cells. Int Immunol 7:1135